Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Xiao Feng Hang"'
Publikováno v:
European journal of clinical pharmacology. 67(6)
High-grade bleeding is a serious adverse event associated with bevacizumab, a humanized monoclonal antibody targeting vascular endothelial growth factor and widely used in the current cancer treatments. The aim of this study was to gain a better unde
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfc0ebbcc093990002ee2ce06f78166d
https://pubmed.ncbi.nlm.nih.gov/21243343
https://pubmed.ncbi.nlm.nih.gov/21243343
Autor:
Hai-Guang Xin1, Bei-Bei Zhang1, Zhi-Qin Wu1, Xiao-Feng Hang1, Wen-Sheng Xu1, Wu Ni1, Rui-Qi Zhang1, Xiao-Hui Miao1 miaoxh2013@hotmail.com
Publikováno v:
European Journal of Pharmacology. Sep2014, Vol. 738, p310-318. 9p.